#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital leptin deficiency Heart disease congenital Pneumonia Solitary fibrous tumour Pancreatic carcinoma Adenocarcinoma pancreas Chronic lymphocytic leukaemia Antiphospholipid antibodies Dementia Small cell lung cancer Paget's disease of the vulva Albright's disease Hereditary hypophosphataemic rickets Monogenic diabetes Alexander disease More trials…

    Learn about Rare Diseases

    Gaucher’s disease type I – Life with Disease Alport’s syndrome – Life with Disease Myxofibrosarcoma – Trials in Disease Systemic sclerosis pulmonary – Trials in Disease Hereditary ataxia – Trials in Disease Osteosarcoma metastatic Rhabdomyosarcoma recurrent – Trials in Disease Hairy cell leukaemia recurrent – Diagnostics Erdheim-Chester disease – Basic Information Pulmonary sarcoidosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    L-PROLINE Mavacamten Hydrochlorothiazide OMEGA-3-ACID ETHYL ESTERS 90 Gsk6097608 Naltrexone Hydrochloride Ipatasertib Reboxetine Tebipenem Pivoxil Hydrobromide Anb032 Piflufolastat (18F) Temocillin Lisinopril Dihydrate Ovolecithin Tiapride Human Von Willebrand Factor Tofacitinib Naloxegol Oxalate Aspartic Acid Granisetron More therapies…

    Learn about Your Condition

    Compulsive sexual behaviour Amnestic disorder Aplasia pure red cell Urea cycle disorder Rubella Genital herpes Heart transplant Thermal burn Becker's muscular dystrophy Choreoathetosis Round cell liposarcoma Gaucher's disease type I Andersen-Tawil syndrome Postoperative wound infection Bronchopulmonary dysplasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Psychological Phenomena

  • Study on the Effectiveness of Reconsolidation Therapy with Propranolol for Patients with Severe Post-Traumatic Stress Disorder

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Post-traumatic stress disorder
    Investigated Drugs:
    • Propranolol Hydrochloride
    Belgium

  • Study on Cannabidiol as an Add-On Treatment for Patients with Severe Alcohol Use Disorder During Inpatient Alcohol Cessation

    Recruiting

    2 1
    Investigated Diseases:
    • Alcohol use disorder
    Investigated Drugs:
    • Cannabidiol
    France

  • A Phase 2 Study of Methylenedioxymethamphetamine‑Assisted Therapy in Young Adults (18‑25) with Chronic Treatment‑Resistant Major Depressive Disorder

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Major depression
    Norway

  • Study of paracetamol effects on emotions and thinking in healthy adults aged 18 to 30 years

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Paracetamol
    Norway

  • A study on ketamine maintenance treatment for patients with treatment-resistant major depression disorder

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Ketamine Hydrochloride
    Norway

  • Study on the Effects of Psilocybin for Young Adults with Anorexia Nervosa

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    Sweden
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!